SCHEMBL8287950

SCHEMBL8287950

O=c1cc(Nc2ccccc2)n(-c2ccccc2)c2cc(Nc3cccc(F)c3)ncc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
MAPT P10636 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
BTK Q06187 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A2 O94788 1/20 0.39
ALDH1A1 P00352 1/20 0.39
ALDH1A3 P47895 1/20 0.39
PIK3CA P42336 1/20 0.39
PRKDC P78527 1/20 0.39
MAPK9 P45984 1/20 0.38
MAPKAPK2 P49137 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
PLK1 P53350 1/20 0.38
FGFR1 P11362 1/20 0.37
SRC P12931 1/20 0.37
EGFR P00533 2/20 0.37
MAT2A P31153 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285309 0.91 BTK (0.43) BTKMEN1KMT2APIK3CAPRKDC
SCHEMBL8362929 0.91 PIK3CA (0.44) MAPTBTKMEN1KMT2APIK3CA
SCHEMBL8287959 0.87 PRKDC (0.46) KDM4EMAPTNPC1RAB9AMEN1
SCHEMBL8286490 0.87 PIK3CA (0.47) KDM4EMAPTNPC1RAB9APIK3CA
SCHEMBL8287951 0.85 BTK (0.42) MAPTBTKMEN1KMT2APIK3CA
SCHEMBL8285319 0.85 PIK3CA (0.43) MAPTNPC1RAB9AMEN1KMT2A
SCHEMBL8285295 0.85 PIK3CA (0.50) KDM4EMAPTNPC1RAB9AMEN1
SCHEMBL8287554 0.82 MEN1 (0.50) KDM4EMAPTNPC1RAB9AMEN1
SCHEMBL8287475 0.81 PIK3CA (0.45) KMT2AALDH1A1PIK3CAPRKDCFGFR1
SCHEMBL8287504 0.81 PRKDC (0.46) NPC1RAB9APIK3CAPRKDCSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed